Examen
PrivateLast Round
Pre Seed
Mar 20, 2026
Total Funding Raised
$4.3M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Examen is an artificial intelligence company that provides a platform for commercial real estate asset managers to automate workflows, reporting, and analysis.
Sector
Enterprise Software
Verticals
Legal Tech, Vertical SaaS, NLP & Conversational AI, Document Management
Business Model
B2B
Customer Profile
Subscription SaaS, Usage-Based SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Examen Comparables
Compare Examen with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Drooms | 34% | |
| Dealpath | 34% | |
| Cherre | 33% | |
Examen Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | Mar 20, 2026 |
Examen Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| GTMfund | Pre Seed |
| Bling Capital | Pre Seed |
| Banyan Ventures | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 27, 2026
Grew 27% QoQ from 11 to 14 employees.
- Mar 20, 2026
$4.3M round led by GTMFund
Examen Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Examen's valuation, stock price, and market status.